BlackRock Fund Advisors’s Atossa Therapeutics ATOS Stock Holding History

BlackRock Fund Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1K	Hold	4	–	–	﹤0.01%	4181
2016 Q3	$1K	Buy	4 +1	+33%	+$600	﹤0.01%	4206
2016 Q2	$2K	Sell	3 -20	-87%	-$16.2K	﹤0.01%	4209
2016 Q1	$22K	Sell	23 -2	-8%	-$1.85K	﹤0.01%	3892
2015 Q4	$21K	Buy	25 +3	+14%	+$4.61K	﹤0.01%	3958
2015 Q3	$47K	Sell	22 -1	-4%	-$2.57K	﹤0.01%	3838
2015 Q2	$70K	Buy	23 +3	+15%	+$12K	﹤0.01%	3788
2015 Q1	$99K	Buy	20 +7	+54%	+$29.9K	﹤0.01%	3630
2014 Q4	$48K	Buy	13 +1	+8%	+$2.82K	﹤0.01%	3677
2014 Q3	$42K	Hold	12	–	–	﹤0.01%	3726
2014 Q2	$57K	Hold	12	–	–	﹤0.01%	3672
2014 Q1	$55K	Buy	12 +1	+9%	+$5.92K	﹤0.01%	3648
2013 Q4	$67K	Buy	11 +1	+10%	+$6.58K	﹤0.01%	3623
2013 Q3	$155K	Buy	10 +1	+11%	+$13.1K	﹤0.01%	3453
2013 Q2	$132K	Buy	+9	New	+$152K	﹤0.01%	3458

Other funds holding ATOS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MFW

Mosaic Family Wealth St. Louis, Missouri $384M AUM 21.14% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

BlackRock Fund Advisors's ATOS Position: Q4 2016 in Review

BlackRock Fund Advisors held its Atossa Therapeutics (ATOS) position steady in Q4 2016 at 4 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #4181.

BlackRock Fund Advisors first reported a position in ATOS in Q2 2013 and has held it in 15 quarters since. The position peaked at $155K in Q3 2013. 10 funds tracked by Wall St. Rank hold ATOS as of Q4 2016.

BlackRock Fund Advisors held 4 shares of Atossa Therapeutics worth $1K as of Q4 2016.
BlackRock Fund Advisors left its Atossa Therapeutics share count unchanged in Q4 2016.
Atossa Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4181 holding.
BlackRock Fund Advisors first reported a position in Atossa Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Atossa Therapeutics position peaked at $155K in Q3 2013.
10 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.